$6.50 -0.02 (-0.31%)
11/25/2009 4:00 PM

Osiris Therapeutics, Inc. (OSIR)

CAPS Rating: 2 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Featured Broker Partners